Term ended Mar 21, 2025 · High confidence
20-year base term ended Jul 7, 2023
USPTO later recorded it as expired for non-payment on Nov 17, 2025.
Held by Collegium Pharmaceutical, Inc.
Filed May 27, 2009 as application 12/473,073 · Granted Oct 15, 2013
Base term plus 623 days of patent term adjustment (USPTO delay)
Today
Term ended Mar 21, 2025
2003
2026
Clock starts
Jul 7, 2003
Jul 7, 2003
Term ended
Mar 21, 2025
Mar 21, 2025
Granted
Oct 15, 2013
Oct 15, 2013
base term
patent term adjustment
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
623
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,399,488, US 7,771,707, to Mar 21, 2025. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
36
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 623 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 7, 2003, when application 10/614,866, the earliest non-provisional in its chain, was filed (this one was filed May 27, 2009) | Jul 7, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +623 days, USPTO patent term adjustment record | Mar 21, 2025 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,399,488, US 7,771,707) | resolves to Mar 21, 2025, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| USPTO status record | Recorded as expired for non-payment on Nov 17, 2025, after the term ended | no change | High confidence |
| Computed term end | The steps above, in order | Mar 21, 2025 | High confidence |
Partial family
| US 7,399,488 | Term ended Mar 2025 | Mar 2025 |
| US 7,771,707 | In force Oct 2028 | Oct 2028 |
| Application 12/112,937 | Abandoned not computed | not computed |
| Application 12/112,993 | Abandoned not computed | not computed |
| US 8,557,291 | this patent Mar 2025 | Mar 2025 |
| US 8,449,909 | Term ended Mar 2025 | Mar 2025 |
| US 8,840,928 | Term ended Jul 2023 | Jul 2023 |
| US 9,044,398 | Term ended Jul 2023 | Jul 2023 |
8 of 36 applications in this family shown, earliest filings first. Partial: 5 of the 36 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 3, 2009 Reel 23600, frame 188 | Rariy, Roman V.; Fleming, Alison B.; Hirsh, Jane; Klibanov, Alexander M. | Collegium Pharmaceutical, Inc. | Assignment of Assignor's Interest |
| Feb 13, 2020 Reel 51817, frame 583 | Collegium Pharmaceutical, Inc. | Biopharma Credit PLC | Security Interest |
| Mar 22, 2022 Reel 59474, frame 526 | Collegium Pharmaceutical, Inc. | Biopharma Credit PLC | Amended and Restated Patent Security Agreement |
| Dec 23, 2025 Reel 73308, frame 342 | Biopharma Credit PLC | Collegium Pharmaceutical, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 623 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,399,488, US 7,771,707, ends no earlier than this term, so it caps nothing.
Citations
101
later US patents cite this one
That is top 5% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.